GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MindBio Therapeutics Corp (FRA:WF6) » Definitions » Short-Term Debt

MindBio Therapeutics (FRA:WF6) Short-Term Debt : €3.05 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is MindBio Therapeutics Short-Term Debt?

MindBio Therapeutics's Short-Term Debt for the quarter that ended in Dec. 2024 was €3.05 Mil.

MindBio Therapeutics's quarterly Short-Term Debt declined from Jun. 2024 (€3.10 Mil) to Sep. 2024 (€3.00 Mil) but then increased from Sep. 2024 (€3.00 Mil) to Dec. 2024 (€3.05 Mil).

MindBio Therapeutics's annual Short-Term Debt increased from Jun. 2022 (€0.00 Mil) to Jun. 2023 (€1.34 Mil) and increased from Jun. 2023 (€1.34 Mil) to Jun. 2024 (€3.10 Mil).


MindBio Therapeutics Short-Term Debt Historical Data

The historical data trend for MindBio Therapeutics's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MindBio Therapeutics Short-Term Debt Chart

MindBio Therapeutics Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Short-Term Debt
0.31 - 1.34 3.10

MindBio Therapeutics Quarterly Data
Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.65 0.65 3.10 3.00 3.05

MindBio Therapeutics Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


MindBio Therapeutics Short-Term Debt Related Terms

Thank you for viewing the detailed overview of MindBio Therapeutics's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


MindBio Therapeutics Business Description

Traded in Other Exchanges
Address
91-97 William Street, Level 4, Melbourne, VIC, AUS, 3000
MindBio Therapeutics Corp is engaged in the research, development, and testing of psychedelic substances as a potential treatment for the management of a broad range of mental health conditions. The company invests in clinical research to discover potential new treatment options and aims to create novel medicines and treatment regimes from breakthrough micro dosing studies. Geographically, the company's activities take place in Australia.

MindBio Therapeutics Headlines

No Headlines